The risk of second malignancies after 125I prostate brachytherapy as monotherapy in a single Australian institution

There may be a small increased risk of bladder SPC after prostate BT. A tendency toward a higher risk of bladder SPC after BT was found within the first 5 years of followup probably reflecting screening bias.